来源:http://www.fsbygjy.com 日期:2017/9/1点击量:1089
来源:风湿病与关节炎,2017,6(8):34-37.
艾拉莫德治疗中重度类风湿关节炎的疗效评价及对骨代谢的影响(临床研究)
马 超,李仿模,陈炜炜
【摘 要】目的:探讨艾拉莫德治疗中重度类风湿关节炎患者骨代谢指标的变化。方法:将64例中重度类风湿关节炎患者随机分为治疗组和对照组,每组32例。对照组给予常规药物治疗,治疗组给予艾拉莫德治疗。2组1个疗程均为24周。比较2组患者骨代谢指标和疾病活动度指标变化。结果:治疗后,2组血清25羟维生素D3指标比较,差异无统计学意义(t = 1.7121,P = 0.0919)。治疗组N-端骨钙素、总Ⅰ型前胶原氨基端延长肽、Ⅰ型胶原降解产物指标明显优于对照组,2组比较,差异有统计学意义(P < 0.05)。2组红细胞沉降率(ESR)、C-反应蛋白、压痛关节数、肿胀关节数指标较治疗前均降低(P < 0.05),且治疗组优于对照组(P < 0.05)。治疗组不良反应发生率34.38%,低于对照组的46.88%。结论:艾拉莫德治疗中重度类风湿关节炎患者24周后骨代谢指标明显改善,疾病活动度减低,不良发应发生减少。
【关键词】 关节炎,类风湿;艾拉莫德;骨代谢指标
Efficacy of Iguratimod in the Treatment of Moderate to Severe Rheumatoid Arthritis and Its Effect on Bone Metabolism
MA Chao,LI Fang-mo,CHEN Wei-wei
【ABSTRACT】Objective:To investigate the changes of bone metabolism in patients with moderate to severe rheumatoid arthritis treated with Iguratimod.Methods:Sixty-four patients with moderate to severe rheumatoid arthritis were randomly divided into a treatment group and a control group,32 cases in each group.The control group was given conventional medicine,and the treatment group was treated with Iguratimod.The two groups were treated for 24 weeks as a course.The changes of bone metabolism index and disease activity index of the two groups were compared.Results:After treatment,there was no significant difference in serum 25 hydroxy vitamin D3 index between the two groups(t = 1.7121,P = 0.0919).The N-MID,Total-PINP and Crosslaps index in the treatment group were significantly better than those in the control group,and the difference between the two groups was statistically significant(P < 0.05).The ESR,C-reactive protein,TJC and swelling joint index of the two groups were lower than before treatment(P < 0.05),and the treatment group was better than the control group(P < 0.05).The incidence of adverse reactions in the treatment group was 34.38%,which was lower than that of the control group(46.88%).Conclusion:After 24-week treatment with Iguratimod,the bone metabolism index of patients with moderate to severe rheumatoid arthritis has significantly improved,and disease activity and adverse reaction have decreased.
【Keywords】arthritis,rheumatoid;Iguratimod;bone metabolism index
![]() |